What Happened? Shares of biotech company Regeneron (NASDAQ:REGN) jumped 2.9% in the morning session after Bank of America ...

Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Regeneron (REGN) and Illumina (ILMN). But which of these two stocks offers value ...

Could the tide be turning for Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) after a surprising shift in analyst sentiment?

Regeneron Pharmaceuticals (NASDAQ: REGN) underwent analysis by 21 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

Recently, Regeneron Pharmaceuticals saw a wave of analyst upgrades from major banks such as Bank of America Securities and ...

Multiple analysts have issued price targets for $REGN recently. We have seen 17 analysts offer price targets for $REGN in the last 6 months, with a median target of ...

Morgan Stanley has lowered its price target on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) to $755 from $958, while maintaining an Overweight rating on the stock. The revision follows what the firm ...

Here is why we believe Regeneron Pharmaceuticals (REGN) stock is worthy of consideration as a value investment. It is presently trading nearly 38% lower than its one-year peak, and is also being ...

Members of Congress have traded $REGN stock 8 times in the past 6 months. Of those trades, 1 have been purchases and 7 have been sales. Here’s a breakdown of recent ...